AIHealthcare Analytics

Knowledge Wiki

Wiki › Forus Health — $150 Million Series C at $3 Billion Valuation

Forus Health — $150 Million Series C at $3 Billion Valuation

ENTITY
Rev 33 Oct 20, 2026 02:21 UTC 1 sources

Forus Health, an AI company focused on ophthalmic and retinal disease detection, has raised $150 million in Series C funding at a $3 billion valuation. The funding round reflects strong investor confidence in specialty AI applications for diagnostics. Company Focus: - AI detection of diabetic retinopathy and other retinal diseases - Ophthalmic screening and diagnosis support - Integration with eye care workflows and EHRs - Deployment in resource-limited settings for eye disease screening Valuation Implications: Forus Health's $3 billion valuation reflects investor appetite for specialized diagnostic AI companies addressing high-prevalence diseases with clear clinical workflows and reimbursement models. Retinal disease screening is a well-defined use case with established clinical pathways. ---

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index